Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
15.02.2023 17:05:00

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CNCE, ISO, TIG

NEW YORK, Feb. 15, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE)'s sale to Sun Pharmaceutical Industries Limited. Per the terms of the agreement, Sun Pharma would acquire Concert for an upfront payment of $8.00 per share in cash, plus a non-tradeable contingent value right entitling Concert shareholders to receive up to an additional $3.50 per share in cash, payable upon deuruxolitinib achieving certain net sales milestones within specified periods. If you are a Concert shareholder, click here to learn more about your rights and options.

IsoPlexis Corporation (NASDAQ: ISO)'s sale to Berkeley Lights, Inc. for 0.612 shares of Berkeley stock for each IsoPlexis share. Following the close of the transaction, IsoPlexis shareholders will own approximately 24.8% of the combined company. If you are an IsoPlexis shareholder, click here to learn more about your rights and options.

Trean Insurance Group, Inc. (NASDAQ: TIG)'s sale to affiliates of Altaris, LLC for $6.15 in cash per share. If you are a Trean shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-cnce-iso-tig-301747582.html

SOURCE Halper Sadeh LLP

Nachrichten zu Concert Pharmaceuticals Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Concert Pharmaceuticals Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!